Get the Stockscreener App
18.62
4.22%
0.755
Shoulder Innovations Inc stock is traded at $18.62, with a volume of 14,254.
It is up +4.22% in the last 24 hours and up +3.76% over the past month.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
See More
Previous Close:
$17.87
Open:
$18.2
24h Volume:
14,254
Relative Volume:
0.12
Market Cap:
$387.75M
Revenue:
$-609.47M
Net Income/Loss:
$-937.91M
P/E Ratio:
-0.6217
EPS:
-29.96
Net Cash Flow:
$96.09M
1W Performance:
+4.11%
1M Performance:
+3.76%
6M Performance:
+22.78%
1Y Performance:
+53.80%
1-Day Range:
$18.20
$19.00
1-Week Range:
$17.75
$18.95
52-Week Range:
$10.92
$24.59
Shoulder Innovations Inc Stock (SI) Company Profile
Name
Shoulder Innovations Inc
Sector
Industry
Phone
616-566-0286
Address
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
18.62 | 387.75M | -609.47M | -937.91M | 96.09M | -29.96 |
ABT
Abbott Laboratories
|
104.52 | 180.86B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.31 | 121.91B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
291.62 | 111.86B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.80 | 63.47B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-26 | Initiated | UBS | Buy |
| Aug-25-25 | Initiated | BTIG Research | Buy |
| Aug-25-25 | Initiated | Goldman | Buy |
| Aug-25-25 | Initiated | Jefferies | Buy |
| Aug-25-25 | Initiated | Piper Sandler | Overweight |
| Mar-06-23 | Downgrade | Compass Point | Neutral → Sell |
| Mar-06-23 | Downgrade | Wedbush | Neutral → Underperform |
| Mar-02-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-23 | Downgrade | Compass Point | Buy → Neutral |
| Mar-02-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-01-23 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jan-06-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-06-23 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-12-22 | Reiterated | Wedbush | Outperform |
| Dec-05-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-21-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-10-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-22 | Downgrade | Goldman | Buy → Neutral |
| Oct-06-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Aug-04-22 | Initiated | BTIG Research | Buy |
| Jun-13-22 | Initiated | Wells Fargo | Overweight |
| Jun-09-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-21-22 | Initiated | BofA Securities | Buy |
| Jan-20-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-16-21 | Initiated | B. Riley Securities | Buy |
| Nov-11-21 | Initiated | JP Morgan | Overweight |
| Nov-08-21 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Sep-27-21 | Initiated | Morgan Stanley | Overweight |
| Jun-14-21 | Initiated | Goldman | Neutral |
| Jan-14-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-22-20 | Initiated | Wedbush | Outperform |
| Dec-17-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Dec-02-20 | Initiated | Craig Hallum | Buy |
| Oct-16-20 | Initiated | Compass Point | Buy |
| Mar-16-20 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | Keefe Bruyette | Mkt Perform |
| Dec-02-19 | Initiated | Barclays | Overweight |
| Nov-18-19 | Initiated | Compass Point | Buy |
View All
Shoulder Innovations Inc Stock (SI) Latest News
Transcript: Shoulder Innovations Q2 2026 Earnings Conference Call - Benzinga
Form 4 Shoulder Innovations Inc For: 11 October By Investing.com - Investing.com South Africa
Shoulder Innovations launches limited release o... - Pluang
Shoulder Innovations begins limited release of InSet Go glenoid implant - StreetInsider
Shoulder Innovations Initiates Commercial Launch of the InSet® Go - PR Newswire
A new shoulder implant was used in its first operation. Its design cuts surgical steps. - Stock Titan
Shoulder Innovations Initiates Commercial Launch of the InSet® Go - TradingView
Form 4 Shoulder Innovations Inc For: 7 October By Investing.com - Investing.com Nigeria
Director fees become a 669-unit stock award at Shoulder Innovations (SI). - Stock Titan
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook - Lelezard
Shoulder Innovations, Inc.(NYSE: SI) added to S&P Global BMI Index - marketscreener.com
Shoulder Innovations breaks ground on new headquarters as sales surge - Crain's Grand Rapids Business
Shoulder Innovations Partners with ALM Ortho on Bespoke Titanium Implants for Complex Shoulder Cases - 3D Printing Industry
Shareholder plans $187,706 stock sale in Shoulder Innovations (SI) - Stock Titan
Shoulder Innovations moving headquarters to Byron Township - Newsradio WOOD 1300 and 106.9 FM
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - WOODTV.com
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - WOODTV.com
Anticipating more growth, medical device company breaks ground on new HQ in Byron Township - Yahoo Finance
Kerry Olin Appointed Chief People Officer at Shoulder Innovations - hrtoday.in
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com South Africa
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com Nigeria
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com Canada
Shoulder Innovations receives FDA clearance for titanium implant - investing.com
Shoulder Innovations Receives FDA 510(K) Clearance For N-22 Humeral Head And Initiates Full Commercial Launch - TradingView
Shoulder Innovations receives FDA clearance for titanium implant By Investing.com - Investing.com UK
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch - PR Newswire
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch - Yahoo Finance
About 10% to 15% of people test positive for metal sensitivity. Shoulder Innovations launches an implant. - Stock Titan
Shoulder Innovations partners with ALM Ortho on implants - investing.com
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - STLtoday.com
Catalyst OrthoScience Announces Settlement of Patent Litigation with Shoulder Innovations - Business Wire
Silvergate ex-CEO blames Biden pressure for bank’s 2023 wind-down - Crypto Briefing
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - PR Newswire
Shoulder Innovations Collaborates With ALM Ortho to Introduce Implant for Shoulder Deformity - Yahoo Finance
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures - Yahoo Finance
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience - Ortho Spine News
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com India
Shoulder Innovations Settles Patent Dispute With Catalyst OrthoScience - marketscreener.com
Shoulder Innovations settles patent dispute with Catalyst - investing.com
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com Canada
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com UK
Shoulder Innovations Announces Settlement of - Moomoo
A patent fight over shoulder surgery ends in settlement. Terms remain confidential. - Stock Titan
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience - PR Newswire
Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com South Africa
Shoulder Innovations (SI) Advances 2.75% as Shares Approach Resistance at $22.17Time Weighted Price - dars.gov.et
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference - Morningstar
Shoulder Innovations to present at Morgan Stanl... - Pluang
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference - AOL.ca
Morgan Stanley healthcare conference sets Sept. 15 chat with Shoulder Innovations - Stock Titan
Shoulder Innovations Inc Stock (SI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shoulder Innovations Inc Stock (SI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ROBERT BALL | Officer |
Sep 14 '26 |
Proposed Sale |
18.45 |
10,175 |
187,706 |
0 |
| Ball Robert Joseph | CEO & Executive Chairman |
Sep 14 '26 |
Sale |
18.45 |
10,175 |
187,706 |
380,824 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 26 '26 |
Sale |
22.60 |
1,196 |
27,030 |
2,185,914 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 24 '26 |
Sale |
22.62 |
681 |
15,404 |
2,187,110 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 21 '26 |
Sale |
22.61 |
20,516 |
463,867 |
2,187,791 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 20 '26 |
Sale |
22.60 |
3,900 |
88,140 |
2,208,307 |
| Ahearn Matthew Fraser | Chief Operating Officer |
Aug 18 '26 |
Sale |
20.99 |
14,186 |
297,704 |
244,176 |
| Ahearn Matthew Fraser | Chief Operating Officer |
Aug 17 '26 |
Sale |
20.10 |
8,314 |
167,101 |
258,362 |
| MATTHEW AHEARN | Director |
Aug 17 '26 |
Proposed Sale |
20.73 |
22,500 |
466,425 |
0 |
| Gilde Healthcare Holding B.V. | 10% Owner |
Aug 06 '26 |
Sale |
22.60 |
2,095 |
47,347 |
2,212,207 |
3.57%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):